In recent years, there have been some notable investments & R&D in the biopharmaceutical industry. The evolution of research fields and innovations, including but not limited to bioengineering & gene therapy, has promoted worldwide laboratory testing & experimenting. In this process, bio-production bottles & containers have played a critical role in storing & handling liquids used for medical experiments & laboratory testing. These bottles are used as an alternative to the traditionally used steel containers & storage systems and prove to be extremely necessary for ensuring that there are no spillages or cross-mixing of solutions & liquids.
Packaging holds extreme significance in almost every industry, including the pharmaceutical sector, where aluminum & glass were the preferred materials earlier. However, since these materials are costly & couldn't deliver economically viable solutions for the packaging of 'products of mass consumption,' the pharmaceutical industry witnessed the emergence of plastic bottles & containers.
Hence, as a consequence of growing medical testing & research, massive pharmaceutical investments, and a rapid surge in need for pharmaceutical bottles, especially since the advent of Covid-19, a recent research report published by MarkNtel Advisors has cited that the Global Bioproduction Bottles Market is expected to witness around 19.29% CAGR during 2022-27.
During the peak period of the pandemic, all healthcare resources & technologies were directed solely at developing treatments, medicines, & vaccines for Covid-19 patients. As a result, there were faster approvals & testing procedures from WHO (World Health Organization), owing to the volatile need to develop vaccines & other medical resources for diseases that require an immediate pharmaceutical response. Due to this, several countries, including Canada, China, & Russia, have emerged as leaders in the bioproduction bottles industry.
Which is the Most Used Material for Bioproduction Bottles?
Glass, aluminum, & plastic, the various materials used for packaging drug formulations, undergo stringent processes in order to determine & ensure their safety & quality standards. However, materials like glass & metal have several disadvantages like high costs, fragility, weight, non-flexibility, and a high coefficient of friction to withstand fluid flow. Moreover, recycling glass bottles requires a large amount of water & washing chemicals, which directly impacts energy consumption & the environment. Hence, due to these aspects, plastics as packaging materials have gained immense popularity worldwide over the previous few years.
Of all plastic types, PET (Polyethylene Terephthalate) has gained significant momentum in the previous few years owing to its quality & safety standards, with extensive utilization in the healthcare sector for packaging liquid oral drug formulations and pediatric & geriatric drugs.
With rigorous testing for being non-toxic, non-carcinogenic, & biocompatible, PET is in no way detrimental to the biological environment. Its safety has been illustrated recursively through various studies, scientific testing, & regulatory approvals, as well as its widespread use & acceptance for numerous years. Hence, based on these aspects, it is the most common form of plastic used in pharmaceutical packaging.
Future Directions of the Bioproduction Bottles Industry
Capital investments in the pharmaceutical R&D departments are gaining traction as biopharmaceutical companies & research-based institutions are working on expanding & outsourcing their production processes across different regions, i.e., proving to be a lucrative opportunity for the bioproduction bottles industry. With multiple companies emerging in the production of pharmaceutical equipment, there are still potential connections & collaborations to be made in order to ensure smooth functioning of the production, distribution, & consumption of bioproduction bottles.
As a result, there needs to be adequate coordination in production processes & supply chain management to overcome challenges associated not only with medical crises such as the recent pandemic but also with economic recessions or political instabilities that ultimately impact the global supply chain of the bioproduction bottles market. Hence, as several bottle & glass manufacturers worldwide are actively working on expanding their production capacities to meet the burgeoning requirements of pharmaceutical firms, it projects a lucrative future ahead for the Global Bioproduction Bottles Market in the years ahead.